These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Intragraft TNF receptor signaling contributes to activation of innate and adaptive immunity in a renal allograft model. Hummel M; Kurian SM; Lin S; Borodyanskiy A; Zhang Z; Li Z; Kim SJ; Salomon DR; Abecassis M Transplantation; 2009 Jan; 87(2):178-88. PubMed ID: 19155971 [TBL] [Abstract][Full Text] [Related]
24. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Fisicaro P; Valdatta C; Boni C; Massari M; Mori C; Zerbini A; Orlandini A; Sacchelli L; Missale G; Ferrari C Gut; 2009 Jul; 58(7):974-82. PubMed ID: 19201769 [TBL] [Abstract][Full Text] [Related]
25. Killers and beyond: NK-cell-mediated control of immune responses. Andoniou CE; Coudert JD; Degli-Esposti MA Eur J Immunol; 2008 Nov; 38(11):2938-42. PubMed ID: 18979519 [TBL] [Abstract][Full Text] [Related]
26. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells. Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157 [TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo effects of mercuric chloride on thymic endocrine activity, NK and NKT cell cytotoxicity, cytokine profiles (IL-2, IFN-gamma, IL-6): role of the nitric oxide-L-arginine pathway. Santarelli L; Bracci M; Mocchegiani E Int Immunopharmacol; 2006 Mar; 6(3):376-89. PubMed ID: 16428073 [TBL] [Abstract][Full Text] [Related]
28. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice. Moulton RA; Mashruwala MA; Smith AK; Lindsey DR; Wetsel RA; Haviland DL; Hunter RL; Jagannath C J Leukoc Biol; 2007 Oct; 82(4):956-67. PubMed ID: 17675563 [TBL] [Abstract][Full Text] [Related]
29. Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection. Tessema TS; Schwamb B; Lochner M; Förster I; Jakobi V; Petry F Immunobiology; 2009; 214(6):454-66. PubMed ID: 19155092 [TBL] [Abstract][Full Text] [Related]
30. Restricted tissue tropism and acquired resistance to Sindbis viral vector expression in the absence of innate and adaptive immunity. Tseng JC; Zheng Y; Yee H; Levy DE; Meruelo D Gene Ther; 2007 Aug; 14(15):1166-74. PubMed ID: 17508007 [TBL] [Abstract][Full Text] [Related]
31. Induction of interferon-gamma from natural killer cells by immunostimulatory CpG DNA is mediated through plasmacytoid-dendritic-cell-produced interferon-alpha and tumour necrosis factor-alpha. Marshall JD; Heeke DS; Abbate C; Yee P; Van Nest G Immunology; 2006 Jan; 117(1):38-46. PubMed ID: 16423039 [TBL] [Abstract][Full Text] [Related]
32. Role of IL-12 in the initiation of cell mediated immunity by Toxoplasma gondii and its regulation by IL-10 and nitric oxide. Gazzinelli RT; Hayashi S; Wysocka M; Carrera L; Kuhn R; Muller W; Roberge F; Trinchieri G; Sher A J Eukaryot Microbiol; 1994; 41(5):9S. PubMed ID: 7804285 [No Abstract] [Full Text] [Related]
33. Oral administration of an Enoki mushroom protein FVE activates innate and adaptive immunity and induces anti-tumor activity against murine hepatocellular carcinoma. Chang HH; Hsieh KY; Yeh CH; Tu YP; Sheu F Int Immunopharmacol; 2010 Feb; 10(2):239-46. PubMed ID: 19909827 [TBL] [Abstract][Full Text] [Related]
34. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT. Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M Exp Hematol; 2008 Feb; 36(2):181-92. PubMed ID: 18023521 [TBL] [Abstract][Full Text] [Related]
35. Neonatal innate cytokine responses to BCG controlling T-cell development vary between populations. van den Biggelaar AH; Prescott SL; Roponen M; Nadal-Sims MA; Devitt CJ; Phuanukoonnon S; Pomat W; Tulic MK; Lehmann D; Siba PM; Richmond PC; Holt PG J Allergy Clin Immunol; 2009 Sep; 124(3):544-50, 550.e1-2. PubMed ID: 19500827 [TBL] [Abstract][Full Text] [Related]
36. Resistance and augmentation of innate immunity in mice exposed to starvation. Shen J; Ren H; Tomiyama-Miyaji C; Watanabe M; Kainuma E; Inoue M; Kuwano Y; Abo T Cell Immunol; 2009; 259(1):66-73. PubMed ID: 19595299 [TBL] [Abstract][Full Text] [Related]
37. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Satoh-Takayama N; Vosshenrich CA; Lesjean-Pottier S; Sawa S; Lochner M; Rattis F; Mention JJ; Thiam K; Cerf-Bensussan N; Mandelboim O; Eberl G; Di Santo JP Immunity; 2008 Dec; 29(6):958-70. PubMed ID: 19084435 [TBL] [Abstract][Full Text] [Related]
38. Attenuated Listeria infection activates natural killer cell cytotoxicity to regress melanoma growth in vivo. Shen H; Kanoh M; Maruyama S; Matsumoto A; Zhang W; Asano Y Microbiol Immunol; 2008 Feb; 52(2):107-17. PubMed ID: 18380808 [TBL] [Abstract][Full Text] [Related]
39. Characterization of Th1 activation by Bartonella henselae stimulation in BALB/c mice: Inhibitory activities of interleukin-10 for the production of interferon-gamma in spleen cells. Kabeya H; Yamasaki A; Ikariya M; Negishi R; Chomel BB; Maruyama S Vet Microbiol; 2007 Jan; 119(2-4):290-6. PubMed ID: 17005337 [TBL] [Abstract][Full Text] [Related]
40. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts). Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]